Echothiophate Iodide Production Cost Reports

The report provides a detailed analysis essential for establishing an echothiophate iodide production plant. It encompasses all critical aspects necessary for echothiophate iodide production, including the cost of echothiophate iodide production, echothiophate iodide plant cost, echothiophate iodide production costs, and the overall echothiophate iodide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an echothiophate iodide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Echothiophate iodide is a specialised phospholine chemical compound that is mainly used in the medical sector, particularly in eye care. It is primarily utilised in ophthalmology for the treatment of certain eye conditions, especially glaucoma, as it helps reduce pressure inside the eye by increasing the outflow of fluid. It is also sometimes used to manage accommodative esotropia, which is a condition where the eyes turn inward due to focusing problems in children. It is mainly used as eye drops in ophthalmology to treat glaucoma, particularly open-angle types, by reducing intraocular pressure through pupil constriction. It works by inhibiting the enzyme cholinesterase, which leads to prolonged activity of acetylcholine, causing the pupil to constrict and reducing eye pressure. Moreover, it is also used as an important compound in research laboratories for studying enzyme inhibition and nerve signal functions. In some cases, it is also used before eye surgery to manage intraocular pressure.

The primary factor that drives the market for echothiophate iodide is its demand as an ocular antihypertensive for the treatment of eye conditions by improving fluid drainage in the eye. Its application as an ocular antihypertensive in the treatment of chronic open-angle glaucoma and accommodative esotropia significantly promotes its demand in the medical and pharmaceutical industries. Its usage as an anti-glaucoma drug for the treatment of glaucoma cases when other medications are not suitable further contributes to its demand in the medical and healthcare sectors.

Its demand as an important compound in the production of eye treatment products and in research settings to facilitate certain biochemical studies also contributes to its market expansion. Moreover, advancements in pharmaceutical production processes, supplier reliability, quality assurance standards, sustainability practices, and efficient distribution networks largely impact industrial echothiophate iodide procurement globally. Additionally, its industrial procurement practices also depend on several factors, including the cost and availability of raw materials, strict regulatory compliance, and safety guidelines due to its strong biological activity.

Raw Material for Echothiophate Iodide Production

According to the echothiophate iodide production plant project report, the major raw materials for echothiophate iodide production include diethylchlorophosphoric acid, 2-dimethylaminoethylmercaptan, and methyl iodide.

Production Process of Echothiophate Iodide

The extensive echothiophate iodide production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of echothiophate iodide begins with the reaction of diethylchlorophosphoric acid and 2-dimethylaminoethylmercaptan to form S-(2-dimethylaminoethyl)-O,O-diethylthiophosphate. Then, this intermediate compound is subjected to an alkylation step using methyl iodide, which adds a methyl group to the nitrogen atom, converting the dimethylamino group into a trimethylammonium group. The complete process results in the formation of echothiophate iodide as a quaternary ammonium salt.

Echothiophate Iodide is the iodide salt of echothiophate, and it acts as a potent, irreversible acetylcholinesterase inhibitor. It appears as a white, crystalline, hygroscopic solid with a slight mercaptan-like odour. The molecular formula of the compound is C9H23INO3PS, and its molar mass is 383.23 g/mol. It is soluble in water and slightly soluble in dimethyl sulfoxide (DMSO) and methanol. Additionally, the compound has a melting point in the range of 124 degree Celsius to 124.5 degree Celsius. It is marketed under the trade name Phospholine Iodide, and it is stored at -20 degree Celsius. The compound is a known toxicant and may cause adverse effects such as bradycardia, hypotension, muscle spasms, blurred vision, blepharospasm, and, with prolonged use, may lead to the formation of cataracts. It is recommended to apply digital compression of the nasolacrimal ducts for one to two minutes following ophthalmic administration to minimise systemic absorption. Moreover, hands should be washed thoroughly after handling the compound to prevent possible skin absorption.